Cargando…

Urokinase receptor is necessary for bacterial defense against Gram-negative sepsis (melioidosis) by facilitating phagoctytosis

Detalles Bibliográficos
Autores principales:	Wiersinga, W Joost, Hovius, JWR, Windt, GJW van der, Meijers, JCM, Roelofs, JJ, Dondorp, A, Levi, M, Day, NP, Peacock, SJ, Poll, T van der
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2776174/ https://www.ncbi.nlm.nih.gov/pubmed/19344483 http://dx.doi.org/10.1186/cc8057

Ejemplares similares

The Urokinase Receptor (uPAR) Facilitates Clearance of Borrelia burgdorferi
por: Hovius, Joppe W. R., et al.
Publicado: (2009)

Overexpression of the Endothelial Protein C Receptor Is Detrimental during Pneumonia-Derived Gram-negative Sepsis (Melioidosis)
por: Kager, Liesbeth M., et al.
Publicado: (2013)

Expression and Function of Macrophage Migration Inhibitory Factor (MIF) in Melioidosis
por: Wiersinga, W. Joost, et al.
Publicado: (2010)

Osteopontin Impairs Host Defense during Established Gram-Negative Sepsis Caused by Burkholderia pseudomallei (Melioidosis)
por: van der Windt, Gerritje J. W., et al.
Publicado: (2010)

Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis
por: Birnie, Emma, et al.
Publicado: (2017)

Correction: Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis
por: Birnie, Emma, et al.
Publicado: (2020)

A Thrombomodulin Mutation that Impairs Active Protein C Generation Is Detrimental in Severe Pneumonia-Derived Gram-Negative Sepsis (Melioidosis)
por: Kager, Liesbeth M., et al.
Publicado: (2014)

The gut microbiota as a modulator of innate immunity during melioidosis
por: Lankelma, Jacqueline M., et al.
Publicado: (2017)

Thrombocytopenia Impairs Host Defense Against Burkholderia pseudomallei (Melioidosis)
por: Birnie, Emma, et al.
Publicado: (2019)

Neutrophil extracellular traps in the host defense against sepsis induced by Burkholderia pseudomallei (melioidosis)
por: de Jong, Hanna K, et al.
Publicado: (2014)

Perasafe, Virkon and bleach are bactericidal for Burkholderia pseudomallei, a select agent and the cause of melioidosis
por: Wuthiekanun, V., et al.
Publicado: (2011)

Triggering Receptor Expressed on Myeloid Cells (TREM)-2 Impairs Host Defense in Experimental Melioidosis
por: Weehuizen, Tassili A. F., et al.
Publicado: (2016)

Glyburide Reduces Bacterial Dissemination in a Mouse Model of Melioidosis
por: Koh, Gavin C. K. W., et al.
Publicado: (2013)

Toll-Like Receptor 2 Impairs Host Defense in Gram-Negative Sepsis Caused by Burkholderia pseudomallei (Melioidosis)
por: Wiersinga, W. Joost, et al.
Publicado: (2007)

Glyburide Is Anti-inflammatory and Associated with Reduced Mortality in Melioidosis
por: Koh, Gavin C. K. W., et al.
Publicado: (2011)

A Graphical Overview of the Histopathology of Human Melioidosis: A Case Series
por: Savelkoel, Jelmer, et al.
Publicado: (2023)

Association between activities related to routes of infection and clinical manifestations of melioidosis
por: Lim, C., et al.
Publicado: (2016)

Emergence of Melioidosis in Indonesia
por: Tauran, Patricia M., et al.
Publicado: (2015)

The Treatment of Melioidosis
por: Inglis, Timothy J.J.
Publicado: (2010)

MyD88 Dependent Signaling Contributes to Protective Host Defense against Burkholderia pseudomallei
por: Wiersinga, W. Joost, et al.
Publicado: (2008)

Drivers of melioidosis endemicity: epidemiological transition, zoonosis, and climate change
por: Birnie, Emma, et al.
Publicado: (2022)

The impact of diabetes on the pathogenesis of sepsis
por: Koh, G. C. K. W., et al.
Publicado: (2011)

Carving difficulties and perinatal death in daughter groups of bulls of the mry breed
por: Mey, GJW van der, et al.
Publicado: (1978)

Clinical, Environmental, and Serologic Surveillance Studies of Melioidosis in Gabon, 2012–2013
por: Wiersinga, W. Joost, et al.
Publicado: (2015)

Melioidosis: The hazards of incomplete peer-review
por: Limmathurotsakul, Direk, et al.
Publicado: (2019)

Revisiting aminocoumarins for the treatment of melioidosis
por: Willcocks, S.J., et al.
Publicado: (2020)

Clinical Definitions of Melioidosis
por: Cheng, Allen C., et al.
Publicado: (2013)

BpOmpW Antigen Stimulates the Necessary Protective T-Cell Responses Against Melioidosis
por: Tomás-Cortázar, Julen, et al.
Publicado: (2021)

Gastrointestinal tract involvement in melioidosis
por: Teparrukkul, Prapit, et al.
Publicado: (2017)

Immunopathophysiology of human sepsis
por: Wiersinga, W. Joost, et al.
Publicado: (2022)

Therapeutic Administration of a Monoclonal Anti-Il-1β Antibody Protects Against Experimental Melioidosis
por: Weehuizen, Tassili A. F., et al.
Publicado: (2016)

Melioidosis, Northeastern Brazil
por: Rolim, Dionne Bezerra, et al.
Publicado: (2005)

Impact of the factor V Leiden mutation on the outcome of pneumococcal pneumonia: a controlled laboratory study
por: Schouten, Marcel, et al.
Publicado: (2010)

Protease-activated receptor-1 impairs host defense in murine pneumococcal pneumonia: a controlled laboratory study
por: Schouten, Marcel, et al.
Publicado: (2012)

Artificial Intelligence for Early Sepsis Detection: A Word of Caution
por: Schinkel, Michiel, et al.
Publicado: (2023)

Melioidosis
por: Annamalai, Anand K., et al.
Publicado: (2019)

Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
por: van der Pluijm, Rob W, et al.
Publicado: (2022)

Limited role for ASC and NLRP3 during in vivo Salmonella Typhimurium infection
por: De Jong, Hanna K, et al.
Publicado: (2014)

Pathogenesis of Sepsis
por: van Engelen, Tjitske S. R., et al.
Publicado: (2017)

Fatal Melioidosis in Goats in Bangkok, Thailand
por: Tonpitak, Walaiporn, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_phi3b1pqh4oquhk86vfm0ngg20